35 related articles for article (PubMed ID: 35768393)
21. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
22. Nonparaneoplastic autoimmune cerebellar ataxias.
Joubert B; Honnorat J
Curr Opin Neurol; 2019 Jun; 32(3):484-492. PubMed ID: 30694927
[TBL] [Abstract][Full Text] [Related]
23. Anti-glutamic acid decarboxylase antibody positive neurological syndromes.
Tohid H
Neurosciences (Riyadh); 2016 Jul; 21(3):215-22. PubMed ID: 27356651
[TBL] [Abstract][Full Text] [Related]
24. Anti-Tr/DNER antibody-associated cerebellar ataxia: three rare cases report and literature review.
Cai Y; Liu J; Ren H; Shi F; Che J; Geng Q; Tan Y; Guan H; Di W
Neurol Sci; 2023 Jan; 44(1):397-403. PubMed ID: 36094774
[TBL] [Abstract][Full Text] [Related]
25. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
26. Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.
Baizabal-Carvallo JF; Alonso-Juarez M
J Neural Transm (Vienna); 2017 Oct; 124(10):1171-1182. PubMed ID: 28689294
[TBL] [Abstract][Full Text] [Related]
27. Immune-mediated ataxias.
Joubert B; Rostásy K; Honnorat J
Handb Clin Neurol; 2018; 155():313-332. PubMed ID: 29891069
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristics and prognosis of patients with anti-glutamic acid decarboxylase antibody-related cerebellar ataxia].
Bai L; Cai Y; Ren HT; Di WY; Liu MG; Fan SY; Guan HZ
Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(25):1935-1937. PubMed ID: 35768393
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune Cerebellar Ataxia: Etiology and Clinical Characteristics of a Case Series from China.
Liu M; Ren H; Zhu Y; Fan S; Bai L; Wang J; Cui L; Guan H
Cerebellum; 2023 Jun; 22(3):379-385. PubMed ID: 35618871
[TBL] [Abstract][Full Text] [Related]
30. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
Mitoma H; Nanri K
Brain Nerve; 2013 Apr; 65(4):355-64. PubMed ID: 23568983
[TBL] [Abstract][Full Text] [Related]
31. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
32. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
Jazebi N; Rodrigo S; Gogia B; Shawagfeh A
J Neuroimmunol; 2019 Jul; 332():135-137. PubMed ID: 31015081
[TBL] [Abstract][Full Text] [Related]
33. [Pediatric autoimmune encephalitis associated with anti-glutamic acid decarboxylase 65 antibody: two cases report and literature review].
Ren CH; Ren HT; Ren XT; Zhang WH; Li JW; Dai LF; Chen CH; Guan HZ; Fang F
Zhonghua Er Ke Za Zhi; 2021 Jan; 59(1):47-52. PubMed ID: 33397004
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
